These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34706797)

  • 1. A Study of Hydrophobically Modified Pullulan Nanoparticles with Different Hydrophobic Densities on the Effect of Anti-Colon Cancer Cell Efficiency.
    Zhang Y; Jiang Q; Liu X; Peng L; Tang X; Li L; Ling X; Yang X; He C; Tao X; Hou D
    J Biomed Nanotechnol; 2021 Oct; 17(10):1972-1983. PubMed ID: 34706797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhetinic acid-cyclodextrin grafted pullulan nanoparticles loaded doxorubicin as a liver targeted delivery carrier.
    Yang W; Zhang Y; Wang J; Li H; Yang H
    Int J Biol Macromol; 2022 Sep; 216():789-798. PubMed ID: 35914549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery.
    Yu Y; Chen CK; Law WC; Weinheimer E; Sengupta S; Prasad PN; Cheng C
    Biomacromolecules; 2014 Feb; 15(2):524-32. PubMed ID: 24446700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
    Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
    Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-Modified Amino-Pullulan Nanoparticles as a Drug Carrier: Comparative Study of Cholesterol-Modified Carboxyethyl Pullulan and Pullulan Nanoparticles.
    Tao X; Xie Y; Zhang Q; Qiu X; Yuan L; Wen Y; Li M; Yang X; Tao T; Xie M; Lv Y; Wang Q; Feng X
    Nanomaterials (Basel); 2016 Sep; 6(9):. PubMed ID: 28335293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery.
    Wang J; Wang M; Zheng M; Guo Q; Wang Y; Wang H; Xie X; Huang F; Gong R
    Colloids Surf B Biointerfaces; 2015 May; 129():63-70. PubMed ID: 25829128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel self-assembled amphiphilic poly(epsilon-caprolactone)-grafted-poly(vinyl alcohol) nanoparticles: hydrophobic and hydrophilic drugs carrier nanoparticles.
    Sheikh FA; Barakat NA; Kanjwal MA; Aryal S; Khil MS; Kim HY
    J Mater Sci Mater Med; 2009 Mar; 20(3):821-31. PubMed ID: 19020953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticles.
    Tao X; Zhang Q; Ling K; Chen Y; Yang W; Gao F; Shi G
    PLoS One; 2012; 7(11):e49304. PubMed ID: 23166632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line.
    Guhagarkar SA; Majee SB; Samad A; Devarajan PV
    Cancer Nanotechnol; 2011; 2(1-6):49-55. PubMed ID: 26069484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient Delivery of DOX to Nuclei of Hepatic Carcinoma Cells in the Subcutaneous Tumor Model Using pH-Sensitive Pullulan-DOX Conjugates.
    Li H; Cui Y; Sui J; Bian S; Sun Y; Liang J; Fan Y; Zhang X
    ACS Appl Mater Interfaces; 2015 Jul; 7(29):15855-65. PubMed ID: 26140410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pullulan derivative with cationic and hydrophobic moieties as an appropriate macromolecule in the synthesis of nanoparticles for drug delivery.
    Constantin M; Bucatariu S; Sacarescu L; Daraba OM; Anghelache M; Fundueanu G
    Int J Biol Macromol; 2020 Dec; 164():4487-4498. PubMed ID: 32946935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular uptake mechanism and intracellular fate of hydrophobically modified pullulan nanoparticles.
    Jiang L; Li X; Liu L; Zhang Q
    Int J Nanomedicine; 2013; 8():1825-34. PubMed ID: 23674894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
    Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
    Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug-Drug Conjugate with High Drug Loading and Antitumor Efficacy.
    Song Q; Wang X; Wang Y; Liang Y; Zhou Y; Song X; He B; Zhang H; Dai W; Wang X; Zhang Q
    Mol Pharm; 2016 Jan; 13(1):190-201. PubMed ID: 26629710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells.
    Shalviri A; Raval G; Prasad P; Chan C; Liu Q; Heerklotz H; Rauth AM; Wu XY
    Eur J Pharm Biopharm; 2012 Nov; 82(3):587-97. PubMed ID: 22995704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel hyaluronic acid coated hydrophobically modified chitosan polyelectrolyte complex for the delivery of doxorubicin.
    Chen L; Zheng Y; Feng L; Liu Z; Guo R; Zhang Y
    Int J Biol Macromol; 2019 Apr; 126():254-261. PubMed ID: 30584933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pH-sensitive nano drug delivery system derived from pullulan/doxorubicin conjugate.
    Lu D; Wen X; Liang J; Gu Z; Zhang X; Fan Y
    J Biomed Mater Res B Appl Biomater; 2009 Apr; 89(1):177-83. PubMed ID: 18777581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
    Elbialy NS; Fathy MM; Khalil WM
    Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Particle Hydrophobicity, Surface Charge, Media pH Value and Complexation with Human Serum Albumin on Drug Release Behavior of Mitoxantrone-Loaded Pullulan Nanoparticles.
    Tao X; Jin S; Wu D; Ling K; Yuan L; Lin P; Xie Y; Yang X
    Nanomaterials (Basel); 2015 Dec; 6(1):. PubMed ID: 28344259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.